#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17490	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2418	882.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1605	1605	C	1118	C,G,T	1115,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	0	.	n	.	0	T695C	SNP	695	695	T	1320	1320	C	996	C,T	995,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1962	1962	A	1187	A,G,C	1184,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2596	2596	C	1044	C,T,G	807,234,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	0	.	n	.	0	C2402T	SNP	2402	2402	C	3027	3027	T	1025	T,C,A	495,528,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2670	2670	A	1016	A,G	1013,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28872	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4146	869.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3222	3222	C	991	C,T,A	987,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2406	folP	855	855	100.0	folP.l15.c4.ctg.1	2045	146.6	1	SNP	p	R229S	0	.	.	685	687	CGC	1328	1330	CGC	243;244;243	C;G;C,G,A	243;244;241,1,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5668	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3859	183.0	1	SNP	p	S91F	0	.	.	271	273	TCC	827	829	TCC	196;195;197	T,C;C,T;C,G,A	195,1;194,1;195,1,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5668	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3859	183.0	1	SNP	p	D95N	0	.	.	283	285	GAC	839	841	GAC	196;200;199	G;A,G;C	196;199,1;199	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5668	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	3859	183.0	1	SNP	p	D95G	0	.	.	283	285	GAC	839	841	GAC	196;200;199	G;A,G;C	196;199,1;199	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2208	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1950	141.3	1	SNP	p	G45D	1	.	.	133	135	GAC	853	855	GAC	229;228;228	G,C,A;A;C	227,1,1;228;228	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1202	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1513	99.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5488	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3446	198.7	1	SNP	p	D86N	0	.	.	256	258	GAC	821	823	GAC	241;238;238	G,T;A;C	240,1;238;238	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5488	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3446	198.7	1	SNP	p	S88P	0	.	.	262	264	TCC	827	829	TCC	243;243;241	T;C;C,G,A	243;243;239,1,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4610	parE	1986	1986	100.0	parE.l6.c30.ctg.1	3292	174.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1836	1838	GGC	233;234;238	G;G;C,G	233;234;236,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1513	1515	GCA	242;240;238	G,T;C;A,G	241,1;240;237,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1516	1518	ATC	238;236;233	A,C;T,C;C	237,1;235,1;233	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1528	1530	GTG	247;249;249	G;T;G,T,C	247;249;247,1,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1528	1530	GTG	247;249;249	G;T;G,T,C	247;249;247,1,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2032	2034	ACC	255;255;254	A,C;C;C	254,1;255;254	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2086	2088	GCG	222;220;219	G,T;C;G	221,1;220;219	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2086	2088	GCG	222;220;219	G,T;C;G	221,1;220;219	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2209	2211	GGC	239;239;239	G;G,T,C;C	239;237,1,1;239	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2218	2220	GGC	246;245;246	G,A;G,C,A;C,G	245,1;243,1,1;245,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4478	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2940	190.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2236	2238	CTG	241;241;242	C;T,G;G	241;240,1;242	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6144	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3751	204.5	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1888	1890	CCG	248;251;247	C,G;C;G	247,1;251;247	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2468	porA	1146	1146	99.83	porA.l6.c30.ctg.1	2578	119.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	776	778	GGC	176;176;175	G;G;C	176;176;175	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2468	porA	1146	1146	99.83	porA.l6.c30.ctg.1	2578	119.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	958	958	C	186	C	186	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	0	.	p	.	0	E38G	NONSYN	112	114	GAA	539	541	GGA	293;292;293	G,C;G;A	292,1;292;293	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	0	.	p	.	0	G46S	NONSYN	136	138	GGC	563	565	AGC	307;304;305	A,G;G;C	306,1;304;305	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	0	.	p	.	0	V98I	NONSYN	292	294	GTC	719	721	ATC	313;309;307	ATC,A;T;C	306,1;309;307	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	0	.	p	.	0	R143E	NONSYN	427	429	AGA	854	856	GAA	315;321;324	G;A;A	315;321;324	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1058	1058	T	319	T	319	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	1	SNP	p	A121D	0	.	.	361	363	GCC	788	790	GCC	289;293;296	G,A;C;C	288,1;293;296	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3630	porB1b	1035	1035	97.8	porB1b.l6.c17.ctg.1	1863	240.2	1	SNP	p	A121N	0	.	.	361	363	GCC	788	790	GCC	289;293;296	G,A;C;C	288,1;293;296	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11532	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5403	266.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1728	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1598	134.9	1	SNP	p	V57M	1	.	.	169	171	ATG	736	738	ATG	305;309;305	A;T;G	305;309;305	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
